SEPHS1 and cancer: Comparative analysis of tumor versus normal tissues showed that enhancer and promoter-5′UTR regions of SEPHS1 exhibited significantly higher methylation levels in several cancers, including bladder urothelial carcinoma and invasive breast carcinoma, further supporting a potential repressive role of DNA methylation on SEPHS1 transcription (Figure S4C).